Axcella Health debuts IPO
Cambridge, Massachusetts-based Axcella Health Inc, a biotech company, has raised $71.4 million for its IPO after pricing its over 3.5 million shares at $20 per share. The stock began trading May 9, 2019 on the NASDAQ under the ticker symbol "AXLA." Goldman Sachs, J.P. Morgan and SVB Leerink are the lead underwriters. Axcella's pre-IPO backers included Gurnet Point Capital, Flagship Pioneering and Enso Ventures.
9 May 2019•3 mins read
